BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9432342)

  • 1. Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication.
    Korman MG; Bolin TD; Engelman JL; Pianko S
    Helicobacter; 1997 Sep; 2(3):140-3. PubMed ID: 9432342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
    Korman MG; Bolin TD; Nicholson FB; Engelman JL
    Helicobacter; 1998 Sep; 3(3):202-5. PubMed ID: 9731992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
    Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
    Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
    Sotudehmanesh R; Malekzadeh R; Fazel A; Massarrat S; Ziad-Alizadeh B; Eshraghian MR
    J Gastroenterol Hepatol; 2001 Mar; 16(3):264-8. PubMed ID: 11339416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
    Tarhini M; Fayyad-Kazan M; Fayyad-Kazan H; Mokbel M; Nasreddine M; Badran B; Kchour G
    Microb Pathog; 2018 Apr; 117():23-26. PubMed ID: 29428426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
    De Boer WA; Driessen WM; Tytgat GN
    Aliment Pharmacol Ther; 1995 Dec; 9(6):633-8. PubMed ID: 8824650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
    Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
    de Boer WA; Driessen WM; Jansz AR; Tytgat GN
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1189-94. PubMed ID: 8789310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication: therapy other than with bismuth or proton-pump inhibitors.
    Korman MG
    Scand J Gastroenterol Suppl; 1996; 220():41-3. PubMed ID: 8898434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
    Gomollón F; Ducóns JA; Gimeno L; Fuentes J; García S; Vera J; Montoro M
    Helicobacter; 1998 Jun; 3(2):110-4. PubMed ID: 9631309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
    Knigge K; Kelly C; Peterson WL; Fennerty MB
    Aliment Pharmacol Ther; 1999 Mar; 13(3):323-6. PubMed ID: 10102965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
    Lai JY; De Boer WA; Driessen WM; Geuskens LM
    Aliment Pharmacol Ther; 1996 Aug; 10(4):645-50. PubMed ID: 8853771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.